ES2175086T3 - Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina. - Google Patents

Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.

Info

Publication number
ES2175086T3
ES2175086T3 ES96911041T ES96911041T ES2175086T3 ES 2175086 T3 ES2175086 T3 ES 2175086T3 ES 96911041 T ES96911041 T ES 96911041T ES 96911041 T ES96911041 T ES 96911041T ES 2175086 T3 ES2175086 T3 ES 2175086T3
Authority
ES
Spain
Prior art keywords
metotrimeprazine
pharmaceutical compositions
compositions containing
emetic
unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96911041T
Other languages
English (en)
Inventor
Philip Malcolm Hallwood
Grahame David Barkby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Link Pharmaceuticals Ltd
Original Assignee
Link Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Link Pharmaceuticals Ltd filed Critical Link Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2175086T3 publication Critical patent/ES2175086T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION ANTIEMETICA NO SEDANTE EN FORMA DE DOSIS UNITARIA ORAL QUE COMPRENDE DE 1 A 5 MG DE METOTRIMEPRAZINA POR DOSIS UNITARIA, O EN UNA FORMA DE DOSIS UNITARIA PARA LA ADMINISTRACION PARENTERAL QUE COMPRENDE DE 1 A 5 MG DE METOTRIMEPRAZINA EN CADA DOSIS UNITARIA.
ES96911041T 1995-04-26 1996-04-24 Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina. Expired - Lifetime ES2175086T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508463.8A GB9508463D0 (en) 1995-04-26 1995-04-26 Anti-emetic pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2175086T3 true ES2175086T3 (es) 2002-11-16

Family

ID=10773543

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96911041T Expired - Lifetime ES2175086T3 (es) 1995-04-26 1996-04-24 Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.

Country Status (8)

Country Link
US (1) US6159965A (es)
EP (1) EP0825864B1 (es)
AU (1) AU5404696A (es)
CA (1) CA2219802C (es)
DE (1) DE69622171T2 (es)
ES (1) ES2175086T3 (es)
GB (2) GB9508463D0 (es)
WO (1) WO1996033721A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003212866A1 (en) * 2002-01-31 2003-12-31 Southwest Research Institute Controlled release compositions and methods for using same
US20050176650A1 (en) * 2004-02-09 2005-08-11 Xanodyne Pharmacal, Inc. Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8426152D0 (en) * 1984-10-16 1984-11-21 Reckitt & Colmann Prod Ltd Medicinal compositions

Also Published As

Publication number Publication date
CA2219802C (en) 2007-10-30
GB2314507A (en) 1998-01-07
DE69622171T2 (de) 2003-02-27
CA2219802A1 (en) 1996-10-31
EP0825864A1 (en) 1998-03-04
GB9508463D0 (en) 1995-06-14
WO1996033721A1 (en) 1996-10-31
EP0825864B1 (en) 2002-07-03
GB2314507B (en) 1999-02-24
AU5404696A (en) 1996-11-18
DE69622171D1 (de) 2002-08-08
GB9722442D0 (en) 1997-12-24
US6159965A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MY115662A (en) Novel compounds with analgesic effect
BR0015188A (pt) Composições farmacêuticas
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
NO20053104D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse for administrering ±n gang pr. dag.
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
ATE214277T1 (de) Schmerzlindernde arzneistoffzusammensetzung
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
ES2116447T3 (es) Una composicion farmaceutica que contiene un sistema definido de lipidos.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
UA29469C2 (uk) Ліпосомальна фармацевтична композиція для внутрішньовенного введення
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
CO4230093A1 (es) Derivados del indol y sus usos medicos
IT1244636B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
NZ320355A (en) Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6- tetrahydropyridine for preparing drugs for treating amyotrophic lateral sclerosis
BR9814127A (pt) Nova forma de dosagem oral para carvedilol
ES2175086T3 (es) Composiciones farmaceuticas anti-emeticas que contienen metotrimeprazina.
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
ES541370A0 (es) Un procedimiento para la preparacion de una composicion de etoposido en forma de dosis unitaria para administracion oral
ES8703872A1 (es) Procedimiento para preparar derivados de isoquinolina.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 825864

Country of ref document: ES